Major depressive disorder (MDD) and bipolar disorder are among the leading causes of disability worldwide. However, their pathophysiological mechanisms ...
October is National Depression Screening Month, and this series of posts will focus on identifying and understanding the palette of variation in major depressive disorder (MDD). In the United States, ...
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...
Researchers at Trinity College Dublin have found that a machine learning model could help clinicians predict which people with depression are more likely to improve with digital cognitive behavioral ...
Rates of depression notably spiked during the pandemic. But even though life has largely returned to normal, we’re still in a mental health crisis. In 2023, the U.S. Surgeon General declared an ...
Johnson & Johnson’s oral add-on drug significantly improved depressive symptoms and sleep outcomes in a phase 3 trial for patients who previously did not benefit from antidepressants alone. The ...
A controlled clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation and the need for larger long-term studies. Study: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results